To date, roles for RelB and p52 reported in the literature appear mostly circumscribed to instances of pluripotent neural stem cells, transformed cells, such as glioma/glioblastoma, and several reports of expression in activated microglia. This evidence concerns the gene NFKB2 and glioblastoma.